SLC5A2 and metabolic syndrome: These variables—including aging, diabetes, hyperglycemia, metabolic syndrome, hypertension, statins, β-blockers, metformin, GLP-1 agonists, SGLT2 inhibitors, heparin, aspirin, and platelet inhibitors—can all interfere with cardioprotective interventions [40,41,42].